Skip to Main Content

Paper Details

A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma.
Clinical Cancer Research
35
2018
CD3, CD3 bi, EGFR, EGFRvIII, EGFRvIII-positive malignant glioma, Human, Human T Cells, Intracerebral Malignant Glioma, Patient, T cells, T-cell, glioma, hEGFRvIII, human, human T cells, malignant glioma, malignant glioma cell lines, nave T cells, patient, patient-derived, patients, scFv, single-chain variable fragments, tumor, tumor cells, tumors
Author NameAffiliation
Roger E McLendonDuke University Medical Center
Stephen T KeirDuke University Medical Center
Stephen T KeirDuke University Medical Center
Darell D BignerDuke University Medical Center
Darell D BignerDuke University Medical Center
Darell D BignerDuke University Medical Center
  • 1 - 6

Datasets

Release 1.2